# Investigating the Effect of Itraconazole on the Pharmacokinetics of AZD4144 in Healthy Participants

> **NCT07685600** · PHASE1 · RECRUITING · sponsor: **AstraZeneca** · enrollment: 32 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD4144
- **DRUG:** AZD4144
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT07685600
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-30
- **Primary completion:** 2026-10-28
- **Final completion:** 2026-10-28
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07685600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07685600, "Investigating the Effect of Itraconazole on the Pharmacokinetics of AZD4144 in Healthy Participants". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07685600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*